{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:51:04Z","timestamp":1721202664779},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to evaluate the association between the cardiac treatment strategy and cardiac event risk in type 2 diabetic patients with coronary artery disease (CAD) based on the history of myocardial infarction. Using Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial data, a Cox proportional hazard model was used for calculating hazard ratios (HRs) for major cardiac events in patients receiving early revascularization or intensive medical therapy. Patients without (<jats:italic>n<\/jats:italic>\u2009=\u20091,557) and with myocardial infarction (<jats:italic>n<\/jats:italic>\u2009=\u2009736) were separately analyzed. In patients without myocardial infarction, risk of major cardiac events was similar for percutaneous coronary intervention and intensive medical therapy groups, whereas it was significantly lower in the coronary artery bypass grafting group than in the intensive medical therapy group (HR: 0.48, 95% confidence interval [95%CI]: 0.30\u20130.76, <jats:italic>P<\/jats:italic>\u2009=\u20090.002). Conversely, in patients with myocardial infarction, risk of major cardiac events was significantly higher in the early revascularization group than in the intensive medical therapy group (HR: 1.47, 95%CI: 1.03\u20132.11, <jats:italic>P<\/jats:italic>\u2009=\u20090.03). In type 2 diabetic patients with CAD, benefits of early revascularization were observed only in those without previous myocardial infarction. For patients with previous myocardial infarction, intensive medical therapy exerted superior benefits.<\/jats:p>","DOI":"10.1038\/s41598-019-39857-0","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T11:05:48Z","timestamp":1551783948000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Tetsuro","family":"Tsujimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kajio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"39857_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2337\/dc08-1296","volume":"32","author":"CC Cowie","year":"2009","unstructured":"Cowie, C. C. et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988\u20131994 and 2005\u20132006. Diabetes Care 32, 287\u2013294 (2009).","journal-title":"Diabetes Care"},{"key":"39857_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang, W. et al. Prevalence of diabetes among men and women in China. The New England journal of medicine 362, 1090\u20131101 (2010).","journal-title":"The New England journal of medicine"},{"key":"39857_CR3","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 352, 837\u2013853 (1998).","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"39857_CR4","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein, H. C. et al. Effects of intensive glucose lowering in type 2 diabetes. The New England journal of medicine 358, 2545\u20132559 (2008).","journal-title":"The New England journal of medicine"},{"key":"39857_CR5","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMicm066227","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel, A. et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England journal of medicine 358, 2560\u20132572 (2008).","journal-title":"The New England journal of medicine"},{"key":"39857_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. The New England journal of medicine 360, 129\u2013139 (2009).","journal-title":"The New England journal of medicine"},{"key":"39857_CR7","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","volume":"360","author":"BDS Group","year":"2009","unstructured":"Group, B. D. S. et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. The New England journal of medicine 360, 2503\u20132515 (2009).","journal-title":"The New England journal of medicine"},{"key":"39857_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/0002-8703(91)91012-C","volume":"122","author":"T Pasierski","year":"1991","unstructured":"Pasierski, T., Pearson, A. C. & Labovitz, A. J. Pathophysiology of isolated systolic hypertension in elderly patients: Doppler echocardiographic insights. Am Heart J 122, 528\u2013534 (1991).","journal-title":"Am Heart J"},{"key":"39857_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.amjcard.2008.11.024","volume":"103","author":"L Schwartz","year":"2009","unstructured":"Schwartz, L. et al. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D). Am J Cardiol 103, 632\u2013638 (2009).","journal-title":"Am J Cardiol"},{"key":"39857_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jacc.2011.05.020","volume":"58","author":"SC Chung","year":"2011","unstructured":"Chung, S. C. et al. The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes). Journal of the American College of Cardiology 58, 810\u2013819 (2011).","journal-title":"Journal of the American College of Cardiology"},{"key":"39857_CR11","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/CIRCULATIONAHA.110.978247","volume":"123","author":"GR Dagenais","year":"2011","unstructured":"Dagenais, G. R. et al. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 123, 1492\u20131500 (2011).","journal-title":"Circulation"},{"key":"39857_CR12","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","volume":"120","author":"BR Chaitman","year":"2009","unstructured":"Chaitman, B. R. et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 120, 2529\u20132540 (2009).","journal-title":"Circulation"},{"key":"39857_CR13","unstructured":"Cox, D. R. a. O. D. Analysis of Survival Data. (Chapman & Hall, 1984)."},{"key":"39857_CR14","unstructured":"Miller, R. G. Jr. Survival Analysis. (Wiley, 1981)."},{"key":"39857_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/01621459.1988.10478612","volume":"83","author":"BL Efron","year":"1988","unstructured":"Efron, B. L. Regression, Survival Analysis, and the Kaplan\u2013Meier Curve. Journal of the American Statistical Association. 83, 414\u2013425 (1988).","journal-title":"Journal of the American Statistical Association."},{"key":"39857_CR16","doi-asserted-by":"crossref","unstructured":"Cox, D. R. Regression Models and Life-Tables. Breakthroughs in statistics. (Springer, 1992).","DOI":"10.1007\/978-1-4612-4380-9_37"},{"key":"39857_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Shchoenfeld","year":"1982","unstructured":"Shchoenfeld, D. Partial residuals for proportional hazards regression model. Biometrika 69, 239\u2013241 (1982).","journal-title":"Biometrika"},{"key":"39857_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-20","volume":"10","author":"CA Bellera","year":"2010","unstructured":"Bellera, C. A. et al. Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC medical research methodology 10, 20 (2010).","journal-title":"BMC medical research methodology"},{"key":"39857_CR19","doi-asserted-by":"crossref","unstructured":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The New England journal of medicine 335, 217\u2013225 (1996).","DOI":"10.1056\/NEJM199607253350401"},{"key":"39857_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jcin.2010.12.004","volume":"4","author":"Y Onuma","year":"2011","unstructured":"Onuma, Y., Wykrzykowska, J. J., Garg, S., Vranckx, P. & Serruys, P. W. 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. JACC. Cardiovascular interventions 4, 317\u2013323 (2011).","journal-title":"JACC. Cardiovascular interventions"},{"key":"39857_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","volume":"43","author":"AP Kappetein","year":"2013","unstructured":"Kappetein, A. P. et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery 43, 1006\u20131013 (2013).","journal-title":"European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery"},{"key":"39857_CR22","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","volume":"367","author":"ME Farkouh","year":"2012","unstructured":"Farkouh, M. E. et al. Strategies for multivessel revascularization in patients with diabetes. The New England journal of medicine 367, 2375\u20132384 (2012).","journal-title":"The New England journal of medicine"},{"key":"39857_CR23","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"SD Fihn","year":"2014","unstructured":"Fihn, S. D. et al. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology 64, 1929\u20131949 (2014).","journal-title":"Journal of the American College of Cardiology"},{"key":"39857_CR24","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryden","year":"2013","unstructured":"Ryden, L. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). European heart journal 34, 3035\u20133087 (2013).","journal-title":"European heart journal"},{"key":"39857_CR25","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker, S. et al. 2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European heart journal 35, 2541\u20132619 (2014).","journal-title":"European heart journal"},{"key":"39857_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MCA.0000000000000492","volume":"28","author":"MJ Chung","year":"2017","unstructured":"Chung, M. J., Novak, E. & Brown, D. L. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Coronary artery disease 28, 301\u2013306 (2017).","journal-title":"Coronary artery disease"},{"key":"39857_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1253\/circj.CJ-16-1002","volume":"81","author":"C Chen","year":"2016","unstructured":"Chen, C., Wei, J., AlBadri, A., Zarrini, P. & Bairey Merz, C. N. Coronary Microvascular Dysfunction- Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy. Circulation journal: official journal of the Japanese Circulation Society 81, 3\u201311 (2016).","journal-title":"Circulation journal: official journal of the Japanese Circulation Society"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39857-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:07:53Z","timestamp":1671260873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39857-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39857"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39857-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3502"}}